NinePoint Medical is a new company developing an optical coherence tomography system for diagnosis of Barrett’s esophagus and dysplasia. The firm just signed a major intellectual property licensing agreement with Massachusetts General Hospital that includes rights to 188 patents and patent applications owned by MGH.
Here’s what a company rep tells Medgadget about its technology:
NinePoint utilizes an advanced form of Fourier-domain optical coherence tomography (OCT) known as OFDI (optical frequency-domain imaging). Developed by Drs. Brett Bouma and Gary Tearney, two leading researchers at Massachusetts General Hospital, OFDI enables physicians to digitally image organs such as the esophagus or gallbladder in less than 60 seconds during an endoscopic procedure. With traditional “point-and-shoot” endoscopic imaging, pathologists must examine multiple images of a patient’s organ. In contrast, NinePoint technology produces a comprehensive, volumetric digital image at microscopic resolution that enables pathologists and treating physicians to see the organ in its entirety – including tissue below the organ’s surface. Starting with the field of gastroenterology, the first two applications of NinePoint’s technology will focus on the initial diagnosis of BE and esophageal dysplasia and surveillance of patients with these conditions after diagnosis and treatment.